Recent Rosacea Blog Posts

Mirvaso Patents to prohibit Generic Mirvaso

Galderma is claiming that the following patents protect their recently FDA Approved Brimonidine Gel known as Mirvaso. These patents are quoted in the Mirvaso Prescribing Information thus forming a public statement by Galderma to any would be competitors. Note one patent is for using Mirvaso to treat the broken blood vessels of rosacea (telangiectasis). This […]

Continue Reading

Step backwards for Generic Oracea. Invalid patents are back

For those following the saga of the possible availability of Generic Oracea in the future, another twist today. Two of the patents that were previously ruled invalid and thus unable to protect Galderma’s product, have now been ruled no longer invalid. This legal ruling will no doubt embolden Galderma that their profitable product Oracea can […]

Continue Reading

Galderma is staking out its claim on potential rosacea topicals with another patent being published. This patent details potential topicals that are combinations of the active ingredients in Sansrosa and Finacea, namely Brimonidine Tartrate and Azelaic Acid. The touted benefits from combining the two actives is a reduction in rebound redness and a greater tolerance […]

Continue Reading

Patent: Rapamycin / Sirolimus to treat Telangiectasia

There are very few existing rosacea treatments for the broken blood vessels and general red face of rosacea. Historically laser and IPL are the only proven treatments for this rosacea subtype. In the last couple of years rosacea sufferers have been encouraged by the development of 2 new drugs that could help treat these symptoms […]

Continue Reading

Generic Finacea sees Bayer suing Glenmark

Bayer AG, owner of Intendis who make Finacea, has sued Mumbai, India’s Glenmark Generics Ltd., seeking to stop sales of a generic form of it’s Finacea gel. Bayer is Germany’s largest drugmaker. Glenmark Pharmaceuticals, a maker of generics, triggered this defensive legal move from Bayer by filing a Abbreviated New Drug Application (ANDA) for a generic […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.